Leerink analyst Mani Foroohar raised the price target on Neurogene (NASDAQ: NGNE) to $77.00 (from $70.00) while maintaining a Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE